In defense of pharmacoepidemiology--embracing the yin and yang of drug research
N Engl J Med
.
2007 Nov 29;357(22):2219-21.
doi: 10.1056/NEJMp0706892.
Author
Jerry Avorn
1
Affiliation
1
Harvard Medical School and Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, USA.
PMID:
18046025
DOI:
10.1056/NEJMp0706892
No abstract available
MeSH terms
Clinical Trials as Topic
Drug Evaluation / methods
Humans
Observation
Pharmacoepidemiology* / trends
Randomized Controlled Trials as Topic